drugset / Trial / NCT03372941

Hospital Avoidance Strategies for ABSSSI

NCT03372941

RandomizedParallel-groupOpen-labelTreatment

Summary

More than 40% of patients presenting with acute bacterial skin and skin structure infection (ABSSSI) to the Barnes-Jewish Hospital (BJH) emergency department (ED) are admitted for intravenous antibiotics. There is growing evidence to suggest that many hospital admissions for uncomplicated ABSSSI due to Gram-positive bacteria could be avoided with an alternative treatment strategy employing newer long-acting antibiotics. Coupled with close outpatient follow-up, such an alternative hospital avoidance strategy has the potential to improve quality and value of care for patients with uncomplicated ABSSSI and optimize use of limited inpatient healthcare resources.

Timeline

Start
2019-03-04
Primary completion
2021-10-14
Completion
2021-10-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dalbavancin Other / unclassified Intravenous

Indications